REVVITY, INC. 8-K
Research Summary
AI-generated summary
Revvity, Inc. Reports Preliminary Q4 2025 Results; JPM Conference Presentation
What Happened
- Revvity, Inc. (RVTY) announced preliminary expectations for its financial results for the fourth quarter ended December 28, 2025 and said it will release full fourth-quarter and full-year 2025 results on February 2, 2026.
- The company furnished a press release (Exhibit 99.1) dated January 12, 2026 regarding the update and also furnished presentation materials (Exhibit 99.2) for a presentation by President and CEO Prahlad Singh at the 44th Annual J.P. Morgan Healthcare Conference.
Key Details
- Quarter covered: Q4 ended December 28, 2025.
- Earnings release and related call scheduled for: February 2, 2026.
- CEO presenting: Prahlad Singh at the 44th Annual J.P. Morgan Healthcare Conference (presentation materials furnished as Exhibit 99.2).
- Press release providing the update was issued January 12, 2026 and furnished as Exhibit 99.1 to the 8-K.
Why It Matters
- Investors should watch the February 2, 2026 earnings release for the company’s final Q4 and full-year 2025 results and any details on revenue, earnings, or outlook that could affect the stock.
- The JP Morgan presentation is an additional forum where management may discuss business performance and strategy; the presentation materials are included with the 8-K for review. Note that the exhibits were furnished with the Form 8-K (not “filed” for certain SEC liabilities).
Loading document...